InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.43
(
-0.20%
)
Bitcoin
60,809.76
(
0.05%
)
Post# of 30387
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Gold Seeker

Send PM Follow Ignore
Followers 29
Posts 9421
Boards Moderated 0
Alias Born 04/30/2006

Gold Seeker

Re: Headache post# 8027

Tuesday, 02/13/2007 12:02:46 PM

Tuesday, February 13, 2007 12:02:46 PM

Post# of 30387
Headache: ?Wrong. Look at the PSA test, which has become a routine screening tool in spite of its inaccuracy."

The PSA test is used because it is something a doctor can use to compliment his decision to do a biospy. Also, if it is negative, you probably do not have prostste cancer. It is merely the best test for prostate cancer the doctor has to offer today.

I still think the company will be sucessful in getting the Abbott/GE RECAF test to market. I just don't want them diluting the shares more on a project that IMO does not warrant the money.
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up